Search Login Register

Epidermodysplasia Verruciformis Summary

Description: An autosomal recessive trait with impaired cell-mediated immunity. About 15 human papillomaviruses are implicated in associated infection, four of which lead to skin neoplasms. The disease begins in childhood with red papules and later spreads over the body as gray or yellow scales.

Also Known As: Lutz-Lewandowsky Disease; Disease, Lewandowsky-Lutz; Disease, Lutz-Lewandowsky; Lewandowsky Lutz Disease; Lutz Lewandowsky Disease Show All >>

Networked: 172 relevant articles (8 outcomes, 11 trials/studies) for this Disease

Key Drugs and Agents for Epidermodysplasia Verruciformis

Efficacy Chart >>
Drugs and Important Biological Agents (IBA) related to treatments:
  1. Interferons : 2 outcomes in 7 results : IBA
  2. Retinoids : 2 outcomes in 3 results : IBA
  3. Vitamin A (Retinol) : 1 outcome in 2 results : FDA 33 Generic
  4. Mitogens : 1 outcome in 2 results : IBA
  5. Interferon-beta : 1 outcome in 1 result : IBA
  6. Isotretinoin (Accutane) : 1 outcome in 1 result : FDA 6 Generic
  7. Zinc : 1 outcome in 1 result : IBA
  8. Ribavirin (Virazole) : 1 outcome in 1 result : FDA 16 Generic
  9. DNA (Deoxyribonucleic Acid) : 5 studies in 57 results : IBA
  10. Viral DNA : 2 studies in 5 results : IBA
Show All >>

Diseases Related to Epidermodysplasia Verruciformis

  1. Neoplasms (Cancer)
  2. Squamous Cell Carcinoma (Epidermoid Carcinoma)
  3. Actinic Keratosis
  4. Basal Cell Carcinoma (Rodent Ulcer)
  5. Skin Diseases
Show All >>

Key Therapies for Epidermodysplasia Verruciformis

Efficacy Chart >>
  1. Highly Active Antiretroviral Therapy (HAART) : 1 outcome in 3 results
  2. Oral Administration : 1 outcome in 1 result
  3. Transplantation (Transplant Recipients) : 1 study in 16 results
  4. Transplants (Transplant) : 1 study in 11 results
  5. Bone Marrow Transplantation (Transplantation, Bone Marrow) : 2 results
Show All >>

CureHunter Inc. provides medical information and specifically does NOT provide medical advice.
© Copyright 2003-2016 CureHunter Inc., MeSH copyright NLM, Journal Articles copyright original owners.